NH THERAGUIX SAS

NH TherAguix SAS Share Price

Stocks

ALNHT

FR0013105954

Market Closed - Euronext Paris 06:04:17 22/10/2021 am IST			5-day change	1st Jan Change
0.0100 ^EUR	-.--%		-.--%	-

03/24/03	NH TherAguix Announces Continuation of Phase II NANOBRAINMETS Trial in Treatment of Brain Metastases After Completion of Futility Analysis	CI
30/24/30	NH TherAguix Appoints Vincent Carrère as CEO	CI

Latest news: NH TherAguix SAS

03/24/03	NH TherAguix Announces Continuation of Phase II NANOBRAINMETS Trial in Treatment of Brain Metastases After Completion of Futility Analysis	CI
30/24/30	NH TherAguix Appoints Vincent Carrère as CEO	CI
30/24/30	NH TherAguix Announces AGuIX Receives Fast Track Designation from U.S. Food and Drug Administration	CI
28/21/28	NH TherAguix SAS and Carbogen AMCIS AG Announce the Release of New Batch of AGuIX Drug Product for Clinical Trials	CI

Press Releases: NH TherAguix SAS

18/24/18	NH TherAguix SAS : Nature’s Scientific Reports publishes an article describing the quantification of novel radio-enhancer AGuIX® developed in brain metastases	PU
19/23/19	NH TherAguix SAS : announces the publication of promising preclinical results of AGuIX® in combination with targeted radioligand therapies (TRT)	PU
12/23/12	NH TherAguix SAS : appoints Vincent Carrère as Chief Executive Officer	PU
21/23/21	NH TherAguix SAS : announces communications to be presented at the AAPM meeting by Harvard Medical Schools collaborators	PU
13/23/13	NH TherAguix SAS : announces the arrival of Aurélien Meyzaud as Head of Intellectual Property and Business Intelligence	PU

More press releases

News in other languages: NH TherAguix SAS

28/21/28

NhTherAguix: NH TherAguix annonce le lancement de son introduction en bourse sur le marché Euronext Growth à Paris

Managers and Directors: NH TherAguix SAS

Manager	Title	Age	Since
Vincent Carrère CEO	Chief Executive Officer	-	01/09/2023
Caroline Cayre DFI	Director of Finance/CFO	-	01/08/2019
Markus Loeffler CTO	Chief Tech/Sci/R&D Officer	-	01/01/2020

Director	Title	Age	Since
Olivier Tillement BRD	Director/Board Member	-	22/02/2019
Hervé Eloi Dominique Brailly CHM	Chairman	64	22/02/2019
Philippe Archinard BRD	Director/Board Member	66	22/02/2019

Financials

	2019	2020
Net sales	10L 9L 8L 7L 13.59L 9.26Cr 13.81L 95.83L 38.23L 4.84Cr 36.48L 35.7L 15Cr	13.24L 11.86L 10.94L 10L 18.51L 13Cr 18.81L 1.31Cr 52.07L 6.6Cr 49.69L 48.63L 21Cr
Net income	-27.03L -24.21L -22.34L -20.21L -37.8L -26Cr -38.41L -2.66Cr -1.06Cr -13Cr -1.01Cr -99.28L -43Cr	-43.45L -38.92L -35.9L -32.49L -60.76L -41Cr -61.74L -4.28Cr -1.71Cr -22Cr -1.63Cr -1.6Cr -69Cr
Net Debt	-	-

* Estimated data More financial data

Company Profile

Employees

14

Sector

-

More about the company

Rankings

Rankings

Currency / Forex

Commodities

Cryptocurrencies

Interest Rates

Stock Market
Stocks
ALNHT Stock

As early as today, start finding the best investment opportunities!